Article published in:
Information Design Journal
Vol. 25:3 (2019) ► pp. 308314
References

References

Black, A., Luna, P., Lund, O., & Walker, S.
(2017) Information design: Research and practice. London: Routledge. CrossrefGoogle Scholar
Collins, P. H.
(1990) Black feminist thought: Knowledge, consciousness, and the politics of empowerment. London: Routledge.Google Scholar
Constanza-Chock, S.
(2020) Design justice: Community-led practices to build the worlds we need. Cambridge, MA: MIT press. CrossrefGoogle Scholar
European Commission
(2017) Report from the commission to the European Parliament and the Council. com(2017) 135 final. https://​ec​.europa​.eu​/health​/sites​/health​/files​/files​/documents​/2017​_03​_report​_smpc​-pl​_en​.pdf
Fuchs, J.
(2010) The way forward in package insert user tests from a CRO’s perspective. Drug Information Journal, 44(2), 19–129. CrossrefGoogle Scholar
Modell, W.
(1967) How to stuff a stuffer and cook a wolf. Pharmacology and Therapeutics, 8(6), 775–781. CrossrefGoogle Scholar
Morris, L. A.
(1989) The FDAs approach to patient package inserts: The four phases of PPIs. In: M. Bogaert, B. Vander Stacee, J-M. Kaufman, & R. Lefebvre (Eds.), Patient package inserts as a source of drug information (pp. 59–66). Amsterdam: Excerpt Medica.Google Scholar
Gibbs, S.
(1990) Informing patients about medicines: An evaluation of prescription information leaflets in general practice (PhD thesis), Faculty of Medicine, University of Southampton.Google Scholar
PIL-S study
(2014) Study on the package leaflets and the summaries of product characteristics of medicinal products for human use. https://​ec​.europa​.eu​/health​/sites​/health​/files​/files​/committee​/75meeting​/pil​_s​.pdf
PIL-BOX study
(2014) Feasibility and value of a possible “key information section” in patient information leaflets and summaries of product characteristics of medicinal products for human use. https://​ec​.europa​.eu​/health​/sites​/health​/files​/files​/committee​/75meeting​/pilbx​.pdf
Rupf, R.
(1991) Evaluation of patient-oriented drug information: Package leaflets as viewed by the patient and their impact on outpatient’s behaviour during treatment. (PhD thesis). University of Basel: Faculty of Philosophy and Natural Sciences.Google Scholar
Sless, D.
(1992) What is information design? In: R. Penman & D. Sless (Eds.), Designing information for people (pp. 1–16). Canberra: Communication Research press.Google Scholar
Sless, D. & Shrensky, R.
(2006) Writing about medicines for people. Australian Self-Medication Industry. [A first edition was published in 1994 by David Sless and Rob Wiseman for the Department of Health and Family Services.] https://​www​.chpaustralia​.com​.au​/Tenant​/C0000022​/Documents​/Publications​/Writing%20About%20Medicines%20for%20People​.pdf
Vander Stichele, R.
(2004) Impact of written drug information in patient package inserts (PhD Thesis). Ghent University, Faculty of Medicine and Health Science.Google Scholar
Van der Waarde, K.
(1993) An investigation into the suitability of the graphic presentation of patient package inserts (PhD thesis). University of Reading, Department of Typography & Graphic Communication.Google Scholar
(2008) Measuring the quality of information in medical package leaflets: Harmful or helpful? Information Design Journal, 16(3), 16–228. CrossrefGoogle Scholar
Walker, S.
(2017) The contribution of typography and information design to health communication. In: E. Tsekleves & R. Cooper (Eds.), Design for health (pp. 92–109). London: Routledge. CrossrefGoogle Scholar